Trials / Completed
CompletedNCT00651690
Study of Responsiveness of Seven Functional Tasks in Patients With Poststroke Upper Limb Spasticity With Botulinum Toxin Type A Treatment
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the responsiveness of 7 functional tasks to botulinum toxin Type A treatment in poststroke patients with spasticity of the upper-limb flexors
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Botulinum Toxin Type A | 200 U to 360 U of botulinum toxin Type A on Day 0. Patients who met retreatment criteria received a second treatment (open-label) at Week 12 or Week 18 |
| BIOLOGICAL | Placebo | Saline injection on Day 0 |
Timeline
- Start date
- 2004-03-01
- Primary completion
- 2005-05-01
- Completion
- 2005-05-01
- First posted
- 2008-04-03
- Last updated
- 2008-05-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00651690. Inclusion in this directory is not an endorsement.